Perspectiva y comprensión bioquímica del síndrome de Down
Down Syndrome (DS) is a chromosomal aberration where 21 chromosome is total or partial duplicate. DS is a common cause for mental retardation and its prevalence in general population is 1/600 to 1/1000 in live borns becoming an important resource spending cause to national public health programs. Em...
- Autores:
-
Montoya Villegas, Julio César
Satizábal Soto, José María
García Vallejo, Felipe
Sánchez Gómez, Adalberto
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2008
- Institución:
- Universidad Autónoma de Occidente
- Repositorio:
- RED: Repositorio Educativo Digital UAO
- Idioma:
- spa
- OAI Identifier:
- oai:red.uao.edu.co:10614/259
- Acceso en línea:
- http://hdl.handle.net/10614/259
- Palabra clave:
- Síndrome de Down
Hiperhomocisteinemia
Hipometilación
- Rights
- openAccess
- License
- Derechos Reservados - Universidad Autónoma de Occidente
Summary: | Down Syndrome (DS) is a chromosomal aberration where 21 chromosome is total or partial duplicate. DS is a common cause for mental retardation and its prevalence in general population is 1/600 to 1/1000 in live borns becoming an important resource spending cause to national public health programs. Embryonary ethiology of DS is associated to non chromosomal disjunction at meiosis I on maternal gametes. However, molecular explanation for this phenomenom is not known. The only epidemiological factor accepted for DS is maternal age. Currently, several research groups have proposed metabolic errors on Folate cycle as a possible factor associated to DS specially genetic mutation on Methylene Tetrahydrofolate Reductase (MTHFR) and Mehionine Synthase Reductase (MTRR). This review shows cur¬rently literature in this topic and proposed an association between high levels of plasmatic homocysteine |
---|